Practice Areas

Legal News

Library

Defective GlucoPro Insulin Syringes Recalled By FDA

According to a press release issued on January 22, 2010, Nipro Medical Corporation, in conjunction with the US Food & Drug Administration, has issued a national recall of GlucoPro insulin syringes. The syringes, which were sold in all 50 states as well as Puerto Rico, were recalled after the medical device manufacturer discovered that the needle may become detached from the syringe. This defective medical device can lead to the needle becoming lodged in the patient’s skin, in the insulin vial, or in the syringe itself.

The medical device recall is voluntary and no injuries have been reported involving the GlucoPro insulin syringe, but Nipro recommends that anyone in possession of the defective product should stop using the needle and return it to the store where it was purchased. If you have been injured because of this defective medical device, report the adverse event to your physician and to the FDA. The recall includes all product codes and lot numbers with expiration dates before November 2011.

Nipro Medical Corporation has notified distributors and customers of the defective syringes. Those with diabetes who regularly use the syringes should be especially aware of the GlucoPro insulin syringe, as should doctors and other health professionals. It should be noted that the Amigo Insulin pump that is used along with the syringe is not defective and patients may continue to use it.

Read More About Defective GlucoPro Insulin Syringes Recalled By FDA...

back to top

Quick Contact